Optimizing AAV and Lentiviral Vector Development
April 15, 2021
Sponsored content brought to you by
Plasmids are essential for the development of viral vectors used to manufacture novel gene therapies and viral vaccines. Aldevron is supporting the innovation of drug developers in this space by providing standardized royalty-free, bulk AAV helper and lentiviral packaging plasmids for research and GMP production.
Importance of Plasmids
Plasmids are circular DNA molecules found mainly in bacteria, but also in yeast and plants, that replicate independently from the host’s chromosomal DNA and enable bacteria to transfer genetic information from one to another via the process of horizontal gene transfer. They may also serve other functions, such as imparting antibiotic resistance. Natural plasmids contain an origin of replication, which controls the host range and copy number of the plasmid and allows initiation of replication. They also generally have at least one other gene that
OXGENE Eyes Further Growth in Cell and Gene Therapy Services after Acquisition.
One of OXGENE’s automated liquid handling systems, among the company’s high throughout discovery and biomanufacturing platforms powered by advanced robotics. WuXi AppTec has acquired the British contract R&D services provider for $135 million, in a deal that gives the Shanghai-based biopharma its first European facility, and broadens its portfolio of technologies for designing and developing scalable cell and gene therapies. [OXGENE]
Global Genome Editing Market Is Expected to Reach USD 17.36 Billion by 2028 : Fior Markets Genome Editing Market by Technology(ZFN, TALENs/MegaTALs, CRISPR/Cas9, Others), Delivery Method (In-Vivo, Ex-Vivo), Application (Cell Line Engineering, Plant Genetic Engineering, Animal Genetic Engineering, Other Applications), End-Use (Contract Research Organizations, Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies), Service (In-house, Contract), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2021 to 2028
February 17, 2021 19:00 ET | Source: Fior Markets Fior Markets Pune, INDIA
Newark, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) As per the report published by Fior Markets, the
global genome editing market is expected to grow from USD 5.37 billion in 2020 to USD 17.36 billion by 2028, at a CAGR of 15.8% during the forecast period 2021-2028.
Global Genome Editing Market Is Expected to Reach USD 17 36 Billion by 2028 : Fior Markets benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.